Literature DB >> 19482603

Depression and pain.

Michael J Robinson1, Sara E Edwards, Smriti Iyengar, Frank Bymaster, Michael Clark, Wayne Katon.   

Abstract

Depression and pain disorders are often diagnosed in the same patients. Here we summarize the shared pathophysiology between both disorders and the importance of addressing all symptoms in patients with comorbid pain and depression. We describe anatomical structures that are activated and/or altered in response to both depression and pain--examples include the insular cortex, the prefrontal cortex, the anterior cingulate cortex, the amygdala, and the hippocampus. Both disorders activate common neurocircuitries (e.g. the hypothalamic-pituitary-adrenal axis, limbic and paralimbic structures, ascending and descending pain tracks), common neurochemicals (e.g. monoamines, cytokines, and neurotrophic factors), and are associated with common psychological alterations. One explanation for the interaction and potentiation of the disease burden experienced by patients affected by both pain and depression is provided by the concept of allostasis. In this model, patients accumulate allostatic load through internal and external stressors, which makes them more susceptible to disease. To break this cycle, it is important to treat all symptoms of a patient. Therapeutic approaches that address symptoms of both depression and pain include psychotherapy, exercise, and pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482603     DOI: 10.2741/3585

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  48 in total

1.  The relationship between pain and mood following spinal cord injury.

Authors:  Paul Kennedy; Laurence Hasson
Journal:  J Spinal Cord Med       Date:  2016-02-17       Impact factor: 1.985

2.  Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products.

Authors:  Yong-Fang Kuo; Mukaila A Raji; Victor Liaw; Jacques Baillargeon; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2018-04-14       Impact factor: 5.562

3.  Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study.

Authors:  A Pizzimenti; M Aragona; E Onesti; M Inghilleri
Journal:  Funct Neurol       Date:  2013 Apr-May

Review 4.  Alcohol dependence as a chronic pain disorder.

Authors:  Mark Egli; George F Koob; Scott Edwards
Journal:  Neurosci Biobehav Rev       Date:  2012-09-11       Impact factor: 8.989

5.  Mood Spectrum Disorders and Perception of Pain.

Authors:  Antonella Ciaramella
Journal:  Psychiatr Q       Date:  2017-12

6.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

7.  L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Authors:  Carla Nasca; Dionysios Xenos; Ylenia Barone; Alessandra Caruso; Sergio Scaccianoce; Francesco Matrisciano; Giuseppe Battaglia; Aleksander A Mathé; Anna Pittaluga; Luana Lionetto; Maurizio Simmaco; Ferdinando Nicoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  The Analgesic and Anxiolytic Effect of Souvenaid, a Novel Nutraceutical, Is Mediated by Alox15 Activity in the Prefrontal Cortex.

Authors:  Suku-Maran Shalini; Deron R Herr; Wei-Yi Ong
Journal:  Mol Neurobiol       Date:  2016-10-01       Impact factor: 5.590

9.  Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Marcus Schiltenwolf
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

10.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.